Surface Oncology, Inc. Common Stock ($0.0001 par value per share) Capital on Demand™ Sales AgreementCapital on Demand Sales Agreement • May 1st, 2019 • Surface Oncology, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 1st, 2019 Company Industry JurisdictionSurface Oncology, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with JONESTRADING INSTITUTIONAL SERVICES LLC (the “Agent”), as follows: